TNFSF10 and breast carcinoma: In addition, breast cancer stem cells (bCSC) are also resistant to TRAIL treatment, but suppressing c-FLIP sensitizes these cells to TRAIL by derepressing the activity of the pro-apoptotic pathway [19].